Global Nuclear Medicine & Radiopharmaceutic Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Nuclear Medicine & Radiopharmaceutic Industry Forecast” looks at past sales and reviews total world Nuclear Medicine & Radiopharmaceutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine & Radiopharmaceutic sales for 2023 through 2029. With Nuclear Medicine & Radiopharmaceutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine & Radiopharmaceutic industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine & Radiopharmaceutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine & Radiopharmaceutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nuclear Medicine & Radiopharmaceutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine & Radiopharmaceutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine & Radiopharmaceutic.
The global Nuclear Medicine & Radiopharmaceutic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nuclear Medicine & Radiopharmaceutic players cover GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine & Radiopharmaceutic market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Nuclear Medicine & Radiopharmaceutic market?
What factors are driving Nuclear Medicine & Radiopharmaceutic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine & Radiopharmaceutic market opportunities vary by end market size?
How does Nuclear Medicine & Radiopharmaceutic break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Nuclear Medicine & Radiopharmaceutic Industry Forecast” looks at past sales and reviews total world Nuclear Medicine & Radiopharmaceutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine & Radiopharmaceutic sales for 2023 through 2029. With Nuclear Medicine & Radiopharmaceutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine & Radiopharmaceutic industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine & Radiopharmaceutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine & Radiopharmaceutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nuclear Medicine & Radiopharmaceutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine & Radiopharmaceutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine & Radiopharmaceutic.
The global Nuclear Medicine & Radiopharmaceutic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nuclear Medicine & Radiopharmaceutic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nuclear Medicine & Radiopharmaceutic players cover GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine & Radiopharmaceutic market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tc-99
- I-123/131
- In-111
- Xe-133
- Th-201
- Ga-67
- Other
- Diagnostic
- Therapeutic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE Healthcare
- Bracco Imaging
- Mallinckrodt
- Lantheus Medical Imaging
- Bayer
- Jubilant Pharma
- Nordion
- Eli Lilly
- SIEMENS
- China Isotope & Radiation
- Yantai Dongcheng Biochemicals
What is the 10-year outlook for the global Nuclear Medicine & Radiopharmaceutic market?
What factors are driving Nuclear Medicine & Radiopharmaceutic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine & Radiopharmaceutic market opportunities vary by end market size?
How does Nuclear Medicine & Radiopharmaceutic break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceutic by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceutic by Country/Region, 2018, 2022 & 2029
2.2 Nuclear Medicine & Radiopharmaceutic Segment by Type
2.2.1 Tc-99
2.2.2 I-123/131
2.2.3 In-111
2.2.4 Xe-133
2.2.5 Th-201
2.2.6 Ga-67
2.2.7 Other
2.3 Nuclear Medicine & Radiopharmaceutic Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
2.3.2 Global Nuclear Medicine & Radiopharmaceutic Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Type (2018-2023)
2.4 Nuclear Medicine & Radiopharmaceutic Segment by Application
2.4.1 Diagnostic
2.4.2 Therapeutic
2.5 Nuclear Medicine & Radiopharmaceutic Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceutic Sale Market Share by Application (2018-2023)
2.5.2 Global Nuclear Medicine & Radiopharmaceutic Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Application (2018-2023)
3 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY COMPANY
3.1 Global Nuclear Medicine & Radiopharmaceutic Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Company (2018-2023)
3.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2018-2023)
3.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Company (2018-2023)
3.2.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Company (2018-2023)
3.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2018-2023)
3.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceutic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine & Radiopharmaceutic Market Size by Geographic Region (2018-2023)
4.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nuclear Medicine & Radiopharmaceutic Market Size by Country/Region (2018-2023)
4.2.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nuclear Medicine & Radiopharmaceutic Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceutic Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceutic Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine & Radiopharmaceutic Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
5.1.2 Americas Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
5.2 Americas Nuclear Medicine & Radiopharmaceutic Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceutic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceutic Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023)
6.1.2 APAC Nuclear Medicine & Radiopharmaceutic Revenue by Region (2018-2023)
6.2 APAC Nuclear Medicine & Radiopharmaceutic Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceutic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine & Radiopharmaceutic by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
7.1.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
7.2 Europe Nuclear Medicine & Radiopharmaceutic Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceutic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceutic by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceutic
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceutic
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceutic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceutic Distributors
11.3 Nuclear Medicine & Radiopharmaceutic Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine & Radiopharmaceutic Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceutic Forecast by Region (2024-2029)
12.1.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceutic Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceutic Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bracco Imaging
13.2.1 Bracco Imaging Company Information
13.2.2 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bracco Imaging Main Business Overview
13.2.5 Bracco Imaging Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Lantheus Medical Imaging
13.4.1 Lantheus Medical Imaging Company Information
13.4.2 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lantheus Medical Imaging Main Business Overview
13.4.5 Lantheus Medical Imaging Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Jubilant Pharma
13.6.1 Jubilant Pharma Company Information
13.6.2 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jubilant Pharma Main Business Overview
13.6.5 Jubilant Pharma Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 SIEMENS
13.9.1 SIEMENS Company Information
13.9.2 SIEMENS Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SIEMENS Main Business Overview
13.9.5 SIEMENS Latest Developments
13.10 China Isotope & Radiation
13.10.1 China Isotope & Radiation Company Information
13.10.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 China Isotope & Radiation Main Business Overview
13.10.5 China Isotope & Radiation Latest Developments
13.11 Yantai Dongcheng Biochemicals
13.11.1 Yantai Dongcheng Biochemicals Company Information
13.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yantai Dongcheng Biochemicals Main Business Overview
13.11.5 Yantai Dongcheng Biochemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceutic by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceutic by Country/Region, 2018, 2022 & 2029
2.2 Nuclear Medicine & Radiopharmaceutic Segment by Type
2.2.1 Tc-99
2.2.2 I-123/131
2.2.3 In-111
2.2.4 Xe-133
2.2.5 Th-201
2.2.6 Ga-67
2.2.7 Other
2.3 Nuclear Medicine & Radiopharmaceutic Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
2.3.2 Global Nuclear Medicine & Radiopharmaceutic Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Type (2018-2023)
2.4 Nuclear Medicine & Radiopharmaceutic Segment by Application
2.4.1 Diagnostic
2.4.2 Therapeutic
2.5 Nuclear Medicine & Radiopharmaceutic Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceutic Sale Market Share by Application (2018-2023)
2.5.2 Global Nuclear Medicine & Radiopharmaceutic Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Application (2018-2023)
3 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY COMPANY
3.1 Global Nuclear Medicine & Radiopharmaceutic Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Company (2018-2023)
3.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2018-2023)
3.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Company (2018-2023)
3.2.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Company (2018-2023)
3.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2018-2023)
3.3 Global Nuclear Medicine & Radiopharmaceutic Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceutic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine & Radiopharmaceutic Market Size by Geographic Region (2018-2023)
4.1.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nuclear Medicine & Radiopharmaceutic Market Size by Country/Region (2018-2023)
4.2.1 Global Nuclear Medicine & Radiopharmaceutic Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nuclear Medicine & Radiopharmaceutic Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceutic Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceutic Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine & Radiopharmaceutic Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
5.1.2 Americas Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
5.2 Americas Nuclear Medicine & Radiopharmaceutic Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceutic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceutic Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023)
6.1.2 APAC Nuclear Medicine & Radiopharmaceutic Revenue by Region (2018-2023)
6.2 APAC Nuclear Medicine & Radiopharmaceutic Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceutic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine & Radiopharmaceutic by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
7.1.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
7.2 Europe Nuclear Medicine & Radiopharmaceutic Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceutic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceutic by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceutic
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceutic
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceutic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceutic Distributors
11.3 Nuclear Medicine & Radiopharmaceutic Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTIC BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine & Radiopharmaceutic Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceutic Forecast by Region (2024-2029)
12.1.2 Global Nuclear Medicine & Radiopharmaceutic Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceutic Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceutic Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bracco Imaging
13.2.1 Bracco Imaging Company Information
13.2.2 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bracco Imaging Main Business Overview
13.2.5 Bracco Imaging Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Lantheus Medical Imaging
13.4.1 Lantheus Medical Imaging Company Information
13.4.2 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lantheus Medical Imaging Main Business Overview
13.4.5 Lantheus Medical Imaging Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Jubilant Pharma
13.6.1 Jubilant Pharma Company Information
13.6.2 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jubilant Pharma Main Business Overview
13.6.5 Jubilant Pharma Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 SIEMENS
13.9.1 SIEMENS Company Information
13.9.2 SIEMENS Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SIEMENS Main Business Overview
13.9.5 SIEMENS Latest Developments
13.10 China Isotope & Radiation
13.10.1 China Isotope & Radiation Company Information
13.10.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 China Isotope & Radiation Main Business Overview
13.10.5 China Isotope & Radiation Latest Developments
13.11 Yantai Dongcheng Biochemicals
13.11.1 Yantai Dongcheng Biochemicals Company Information
13.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
13.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yantai Dongcheng Biochemicals Main Business Overview
13.11.5 Yantai Dongcheng Biochemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine & Radiopharmaceutic Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceutic Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tc-99
Table 4. Major Players of I-123/131
Table 5. Major Players of In-111
Table 6. Major Players of Xe-133
Table 7. Major Players of Th-201
Table 8. Major Players of Ga-67
Table 9. Major Players of Other
Table 10. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 11. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Table 12. Global Nuclear Medicine & Radiopharmaceutic Revenue by Type (2018-2023) & ($ million)
Table 13. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2018-2023)
Table 14. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Type (2018-2023) & (US$/Ton)
Table 15. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 16. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Table 17. Global Nuclear Medicine & Radiopharmaceutic Revenue by Application (2018-2023)
Table 18. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2018-2023)
Table 19. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Application (2018-2023) & (US$/Ton)
Table 20. Global Nuclear Medicine & Radiopharmaceutic Sales by Company (2018-2023) & (Kiloton)
Table 21. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2018-2023)
Table 22. Global Nuclear Medicine & Radiopharmaceutic Revenue by Company (2018-2023) ($ Millions)
Table 23. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2018-2023)
Table 24. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Company (2018-2023) & (US$/Ton)
Table 25. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Producing Area Distribution and Sales Area
Table 26. Players Nuclear Medicine & Radiopharmaceutic Products Offered
Table 27. Nuclear Medicine & Radiopharmaceutic Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Nuclear Medicine & Radiopharmaceutic Sales by Geographic Region (2018-2023) & (Kiloton)
Table 31. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Geographic Region (2018-2023)
Table 32. Global Nuclear Medicine & Radiopharmaceutic Revenue by Geographic Region (2018-2023) & ($ millions)
Table 33. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Geographic Region (2018-2023)
Table 34. Global Nuclear Medicine & Radiopharmaceutic Sales by Country/Region (2018-2023) & (Kiloton)
Table 35. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country/Region (2018-2023)
Table 36. Global Nuclear Medicine & Radiopharmaceutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 37. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country/Region (2018-2023)
Table 38. Americas Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 39. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 40. Americas Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 41. Americas Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 42. Americas Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 43. Americas Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 44. APAC Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (Kiloton)
Table 45. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2018-2023)
Table 46. APAC Nuclear Medicine & Radiopharmaceutic Revenue by Region (2018-2023) & ($ Millions)
Table 47. APAC Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2018-2023)
Table 48. APAC Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 49. APAC Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 50. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 51. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 52. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 53. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 54. Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 55. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 58. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 59. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 60. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 61. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 62. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceutic
Table 63. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceutic
Table 64. Key Industry Trends of Nuclear Medicine & Radiopharmaceutic
Table 65. Nuclear Medicine & Radiopharmaceutic Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Nuclear Medicine & Radiopharmaceutic Distributors List
Table 68. Nuclear Medicine & Radiopharmaceutic Customer List
Table 69. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Americas Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Americas Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. APAC Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2024-2029) & (Kiloton)
Table 74. APAC Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 75. Europe Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 76. Europe Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 78. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Type (2024-2029) & (Kiloton)
Table 80. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 81. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Application (2024-2029) & (Kiloton)
Table 82. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 83. GE Healthcare Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 84. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 85. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. GE Healthcare Main Business
Table 87. GE Healthcare Latest Developments
Table 88. Bracco Imaging Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 89. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 90. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Bracco Imaging Main Business
Table 92. Bracco Imaging Latest Developments
Table 93. Mallinckrodt Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 94. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 95. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Mallinckrodt Main Business
Table 97. Mallinckrodt Latest Developments
Table 98. Lantheus Medical Imaging Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 99. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 100. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Lantheus Medical Imaging Main Business
Table 102. Lantheus Medical Imaging Latest Developments
Table 103. Bayer Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 105. Bayer Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Jubilant Pharma Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 109. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 110. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Jubilant Pharma Main Business
Table 112. Jubilant Pharma Latest Developments
Table 113. Nordion Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 114. Nordion Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 115. Nordion Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Nordion Main Business
Table 117. Nordion Latest Developments
Table 118. Eli Lilly Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 119. Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 120. Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Eli Lilly Main Business
Table 122. Eli Lilly Latest Developments
Table 123. SIEMENS Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 124. SIEMENS Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 125. SIEMENS Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. SIEMENS Main Business
Table 127. SIEMENS Latest Developments
Table 128. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 129. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 130. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. China Isotope & Radiation Main Business
Table 132. China Isotope & Radiation Latest Developments
Table 133. Yantai Dongcheng Biochemicals Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 134. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 135. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Yantai Dongcheng Biochemicals Main Business
Table 137. Yantai Dongcheng Biochemicals Latest Developments
Table 1. Nuclear Medicine & Radiopharmaceutic Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceutic Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tc-99
Table 4. Major Players of I-123/131
Table 5. Major Players of In-111
Table 6. Major Players of Xe-133
Table 7. Major Players of Th-201
Table 8. Major Players of Ga-67
Table 9. Major Players of Other
Table 10. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 11. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Table 12. Global Nuclear Medicine & Radiopharmaceutic Revenue by Type (2018-2023) & ($ million)
Table 13. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2018-2023)
Table 14. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Type (2018-2023) & (US$/Ton)
Table 15. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 16. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Table 17. Global Nuclear Medicine & Radiopharmaceutic Revenue by Application (2018-2023)
Table 18. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2018-2023)
Table 19. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Application (2018-2023) & (US$/Ton)
Table 20. Global Nuclear Medicine & Radiopharmaceutic Sales by Company (2018-2023) & (Kiloton)
Table 21. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2018-2023)
Table 22. Global Nuclear Medicine & Radiopharmaceutic Revenue by Company (2018-2023) ($ Millions)
Table 23. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2018-2023)
Table 24. Global Nuclear Medicine & Radiopharmaceutic Sale Price by Company (2018-2023) & (US$/Ton)
Table 25. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Producing Area Distribution and Sales Area
Table 26. Players Nuclear Medicine & Radiopharmaceutic Products Offered
Table 27. Nuclear Medicine & Radiopharmaceutic Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Nuclear Medicine & Radiopharmaceutic Sales by Geographic Region (2018-2023) & (Kiloton)
Table 31. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Geographic Region (2018-2023)
Table 32. Global Nuclear Medicine & Radiopharmaceutic Revenue by Geographic Region (2018-2023) & ($ millions)
Table 33. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Geographic Region (2018-2023)
Table 34. Global Nuclear Medicine & Radiopharmaceutic Sales by Country/Region (2018-2023) & (Kiloton)
Table 35. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country/Region (2018-2023)
Table 36. Global Nuclear Medicine & Radiopharmaceutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 37. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country/Region (2018-2023)
Table 38. Americas Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 39. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 40. Americas Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 41. Americas Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 42. Americas Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 43. Americas Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 44. APAC Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (Kiloton)
Table 45. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2018-2023)
Table 46. APAC Nuclear Medicine & Radiopharmaceutic Revenue by Region (2018-2023) & ($ Millions)
Table 47. APAC Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2018-2023)
Table 48. APAC Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 49. APAC Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 50. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 51. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 52. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 53. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 54. Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 55. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2018-2023)
Table 58. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2018-2023) & ($ Millions)
Table 59. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2018-2023)
Table 60. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)
Table 61. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)
Table 62. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceutic
Table 63. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceutic
Table 64. Key Industry Trends of Nuclear Medicine & Radiopharmaceutic
Table 65. Nuclear Medicine & Radiopharmaceutic Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Nuclear Medicine & Radiopharmaceutic Distributors List
Table 68. Nuclear Medicine & Radiopharmaceutic Customer List
Table 69. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Americas Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Americas Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. APAC Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2024-2029) & (Kiloton)
Table 74. APAC Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 75. Europe Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 76. Europe Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Forecast by Country (2024-2029) & (Kiloton)
Table 78. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Type (2024-2029) & (Kiloton)
Table 80. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 81. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Application (2024-2029) & (Kiloton)
Table 82. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 83. GE Healthcare Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 84. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 85. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. GE Healthcare Main Business
Table 87. GE Healthcare Latest Developments
Table 88. Bracco Imaging Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 89. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 90. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Bracco Imaging Main Business
Table 92. Bracco Imaging Latest Developments
Table 93. Mallinckrodt Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 94. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 95. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Mallinckrodt Main Business
Table 97. Mallinckrodt Latest Developments
Table 98. Lantheus Medical Imaging Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 99. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 100. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Lantheus Medical Imaging Main Business
Table 102. Lantheus Medical Imaging Latest Developments
Table 103. Bayer Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 105. Bayer Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Jubilant Pharma Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 109. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 110. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Jubilant Pharma Main Business
Table 112. Jubilant Pharma Latest Developments
Table 113. Nordion Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 114. Nordion Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 115. Nordion Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Nordion Main Business
Table 117. Nordion Latest Developments
Table 118. Eli Lilly Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 119. Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 120. Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Eli Lilly Main Business
Table 122. Eli Lilly Latest Developments
Table 123. SIEMENS Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 124. SIEMENS Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 125. SIEMENS Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. SIEMENS Main Business
Table 127. SIEMENS Latest Developments
Table 128. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 129. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 130. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. China Isotope & Radiation Main Business
Table 132. China Isotope & Radiation Latest Developments
Table 133. Yantai Dongcheng Biochemicals Basic Information, Nuclear Medicine & Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors
Table 134. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Portfolios and Specifications
Table 135. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Yantai Dongcheng Biochemicals Main Business
Table 137. Yantai Dongcheng Biochemicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine & Radiopharmaceutic
Figure 2. Nuclear Medicine & Radiopharmaceutic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceutic Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceutic Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tc-99
Figure 10. Product Picture of I-123/131
Figure 11. Product Picture of In-111
Figure 12. Product Picture of Xe-133
Figure 13. Product Picture of Th-201
Figure 14. Product Picture of Ga-67
Figure 15. Product Picture of Other
Figure 16. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type in 2022
Figure 17. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2018-2023)
Figure 18. Nuclear Medicine & Radiopharmaceutic Consumed in Diagnostic
Figure 19. Global Nuclear Medicine & Radiopharmaceutic Market: Diagnostic (2018-2023) & (Kiloton)
Figure 20. Nuclear Medicine & Radiopharmaceutic Consumed in Therapeutic
Figure 21. Global Nuclear Medicine & Radiopharmaceutic Market: Therapeutic (2018-2023) & (Kiloton)
Figure 22. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2022)
Figure 23. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application in 2022
Figure 24. Nuclear Medicine & Radiopharmaceutic Sales Market by Company in 2022 (Kiloton)
Figure 25. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company in 2022
Figure 26. Nuclear Medicine & Radiopharmaceutic Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company in 2022
Figure 28. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 31. Americas Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 32. APAC Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 33. APAC Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 34. Europe Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 35. Europe Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 37. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 38. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 39. Americas Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 40. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 41. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 42. United States Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region in 2022
Figure 47. APAC Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Regions in 2022
Figure 48. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 49. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 50. China Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 58. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 59. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 60. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 61. Germany Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 70. Egypt Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceutic in 2022
Figure 76. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceutic
Figure 77. Industry Chain Structure of Nuclear Medicine & Radiopharmaceutic
Figure 78. Channels of Distribution
Figure 79. Global Nuclear Medicine & Radiopharmaceutic Sales Market Forecast by Region (2024-2029)
Figure 80. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Nuclear Medicine & Radiopharmaceutic
Figure 2. Nuclear Medicine & Radiopharmaceutic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceutic Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceutic Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tc-99
Figure 10. Product Picture of I-123/131
Figure 11. Product Picture of In-111
Figure 12. Product Picture of Xe-133
Figure 13. Product Picture of Th-201
Figure 14. Product Picture of Ga-67
Figure 15. Product Picture of Other
Figure 16. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type in 2022
Figure 17. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2018-2023)
Figure 18. Nuclear Medicine & Radiopharmaceutic Consumed in Diagnostic
Figure 19. Global Nuclear Medicine & Radiopharmaceutic Market: Diagnostic (2018-2023) & (Kiloton)
Figure 20. Nuclear Medicine & Radiopharmaceutic Consumed in Therapeutic
Figure 21. Global Nuclear Medicine & Radiopharmaceutic Market: Therapeutic (2018-2023) & (Kiloton)
Figure 22. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2022)
Figure 23. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application in 2022
Figure 24. Nuclear Medicine & Radiopharmaceutic Sales Market by Company in 2022 (Kiloton)
Figure 25. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company in 2022
Figure 26. Nuclear Medicine & Radiopharmaceutic Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company in 2022
Figure 28. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 31. Americas Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 32. APAC Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 33. APAC Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 34. Europe Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 35. Europe Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales 2018-2023 (Kiloton)
Figure 37. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue 2018-2023 ($ Millions)
Figure 38. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 39. Americas Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 40. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 41. Americas Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 42. United States Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region in 2022
Figure 47. APAC Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Regions in 2022
Figure 48. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 49. APAC Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 50. China Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 58. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 59. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 60. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 61. Germany Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2018-2023)
Figure 70. Egypt Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Nuclear Medicine & Radiopharmaceutic Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceutic in 2022
Figure 76. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceutic
Figure 77. Industry Chain Structure of Nuclear Medicine & Radiopharmaceutic
Figure 78. Channels of Distribution
Figure 79. Global Nuclear Medicine & Radiopharmaceutic Sales Market Forecast by Region (2024-2029)
Figure 80. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Application (2024-2029)
